Health

AI ยท 251 companies ยท 438 deals tracked
251 Companies
438 Deals Tracked
AI Sector

Health Companies

Eclipsebio Eclipsebio ๐Ÿ‡บ๐Ÿ‡ธ Valerie Health Valerie Health ๐Ÿ‡บ๐Ÿ‡ธ Shanx Medtech Shanx Medtech ๐Ÿ‡ณ๐Ÿ‡ฑ Linda AI Linda AI ๐Ÿ‡ฎ๐Ÿ‡ช Uk Research And Innovation Uk Research And Innovation ๐Ÿ‡ฌ๐Ÿ‡ง Qt Sense Qt Sense ๐Ÿ‡ณ๐Ÿ‡ฑ Coherence Neuro Coherence Neuro ๐Ÿ‡บ๐Ÿ‡ธ Custom Surgical Custom Surgical ๐Ÿ‡ฉ๐Ÿ‡ช Outpost Bio Outpost Bio ๐Ÿ‡ฌ๐Ÿ‡ง Neuropacs Neuropacs ๐Ÿ‡บ๐Ÿ‡ธ

Latest Deals in Health

$40M
answersnow has raised $40 million in Series B funding led by HealthQuest Capital, with participation from Left Lane Capital and Owl Ventures. The company provides virtual applied behavioral analysis therapy, achieving clinically significant outcomes in one-sixth the hours of traditional therapy, thus reducing costs for payors by up to 75%. The new funding will be used to scale operations, double clinical staff, and enhance AI capabilities for personalized therapy. In 2025, answersnow facilitated nearly 100,000 hours of therapy, with 96% of families reporting meaningful improvements.
Investors: HealthQuest Capital, Left Lane Capital, Owl Ventures
Health Jan 21, 2026
$59.94M
Munich-based Orbem has raised โ‚ฌ55.5 million in a Series B funding round led by Innovation Industries, with participation from Supernova Invest and existing investors. Orbem utilizes AI to industrialize magnetic resonance imaging for non-invasive analysis of biological materials, addressing challenges in agriculture, food production, and health. Their flagship product, Genus Focus, determines the sex of poultry eggs rapidly, offering a humane alternative to culling. The funding will support U.S. expansion and entry into the fruit and vegetable sector.
Investors: Innovation Industries, Supernova Invest
Health Jan 21, 2026
$8M
Biomakers, a precision medicine and oncology intelligence company based in San Francisco, has secured an additional $8 million in funding. This investment will help the company transition to an AI-native platform aimed at enhancing drug and diagnostic development, improving clinical trial execution, and broadening access to precision oncology worldwide. Key investors include Labcorp Venture Fund, Oncology Ventures, and others.
Investors: Labcorp Venture Fund, Oncology Ventures
Health Jan 21, 2026
$59.94M
Orbem has secured โ‚ฌ55.5 million in Series B funding to enhance its efforts in creating a healthier and more sustainable future. The funding round was led by Innovation Industries and included participation from Supernova Invest, along with continued support from existing investors such as General Catalyst, 83North, The Venture Collective (TVC), and Possible Ventures.
Investors: Innovation Industries, Supernova Invest, General Catalyst, 83North, The Venture Collective (TVC), Possible Ventures
Health Jan 20, 2026
$13M
BrightInsight, a San Jose, CA-based company specializing in digital health solutions, raised $13 million in funding. The investment was backed by Eclipse, General Catalyst, Insight Partners, Mayo Clinic, and New Leaf Venture Partners. The funds will be used to accelerate the development of its AI-enabled medication persistence and adherence solutions, including a patient app.
Investors: Eclipse, General Catalyst, Insight Partners, Mayo Clinic, New Leaf Venture Partners
Health Jan 20, 2026
$1M
Neuropacs has raised over $1 million in seed financing to enhance its AI-driven neurological diagnostic software, aimed at addressing neurodegenerative parkinsonism. The funding will support product development and prepare for wider clinical commercialization.
Health Jan 20, 2026
$12M
Belfast-based AI health-tech company Eolas Medical has raised $12 million in Series A funding to enhance its AI platform used in over 400 clinical sites within the UK's National Health Service. The platform aims to provide healthcare professionals with quick access to reliable information, improving decision-making speed and quality. Acton Capital led the funding round, highlighting strong clinician support for Eolas's innovative solution.
Investors: Acton Capital
Health Jan 20, 2026
$1M
Neuropacs, a Gainesville, FL-based AI-driven neurological diagnostics company, raised over $1 million in seed funding from backers including Neuro Investment Group. The funds will be used to accelerate technology development, recruit key personnel, and establish strategic partnerships. Led by CEO Dr. Martin Handfield, Neuropacs specializes in automated MRI processing.
Investors: Neuro Investment Group
Health Jan 20, 2026
$59.94M
Munich-based Orbem has secured โ‚ฌ55.5 million in a Series B financing round led by Innovation Industries, with participation from Supernova Invest and existing backers like General Catalyst. Orbem leverages AI for non-invasive magnetic resonance imaging to analyze biological materials, addressing challenges in agriculture and food production. Its flagship product, Genus Focus, determines poultry egg sex in under one second, reducing the need for culling male chicks. The funding will facilitate expansion into the U.S. and the fruit and vegetable sector, while enhancing healthcare applications.
Investors: Innovation Industries, Supernova Invest, General Catalyst
Health Jan 20, 2026
$59.94M
Orbem, a Munich-based deep tech company, has secured โ‚ฌ55.5 million in a Series B funding round led by Innovation Industries, with participation from Supernova Invest and others. The company has developed technology that utilizes MRI sensors combined with AI to non-invasively analyze biological materials, addressing issues in agriculture such as chick culling. Their flagship product can determine the sex of chick embryos in under a second, aligning with EU regulations and consumer demands. The funding will support Orbem's expansion into the U.S. market and new sectors.
Investors: Innovation Industries, Supernova Invest
Health Jan 20, 2026
$2.7M
Cancilico, a Dresden-based AI diagnostics startup focused on blood cancers, has raised โ‚ฌ2.5 million in seed funding. The company aims to automate and enhance the accuracy of blood and bone marrow analysis through its flagship product, Myeloaid. The investment was led by a consortium including High-Tech Grรผnderfonds and Technologiegrรผnderfonds Sachsen, among others. This funding will help navigate regulatory landscapes and improve patient outcomes without significant capital expenditure.
Investors: High-Tech Grรผnderfonds, Technologiegrรผnderfonds Sachsen
Health Jan 20, 2026
$2.7M
Cancilico, a Dresden-based AI diagnostics startup specializing in blood cancer, has raised โ‚ฌ2.5 million in seed funding. The company aims to automate and enhance the accuracy of blood and bone marrow analysis through its AI-driven solution, Myeloaid. The investment was led by a consortium including High-Tech Grรผnderfonds and others, with the goal of improving patient outcomes and addressing the global shortage of hematologists.
Investors: High-Tech Grรผnderfonds
Health Jan 20, 2026
Instinct Science has acquired ScribbleVet, a leading veterinary AI scribing platform, to create the first clinical intelligence platform for veterinary practice management. This acquisition aims to reduce administrative burdens and enhance efficiency through AI-driven workflows and decision support. The combined platform will support over 360,000 veterinary professionals worldwide, with ScribbleVet's founder, Rohan Relan, taking a leadership role in product strategy. Instinct Science, founded in 2017 by Dr. Caleb Frankel, is focused on transforming veterinary medicine with innovative software.
Health Jan 19, 2026
$12M
Eolas Medical has raised $12 million in a Series A round led by Acton Capital to scale its AI-driven point-of-care knowledge platform in the NHS. The Belfast-based healthtech company, already utilized in over 400 UK clinical sites, aims to provide healthcare professionals with faster access to essential information, addressing the increasing demand for consistent clinical guidance. The investment reflects strong enthusiasm from clinicians for Eolas's product, which enhances decision-making in acute settings.
Investors: Acton Capital
Health Jan 19, 2026
Instinct Science, an animal health technology company, has acquired ScribbleVet, an AI scribing platform for veterinarians. This acquisition aims to create the industry's first 'clinical intelligence platform,' which will integrate AI documentation, workflow automation, and clinical decision support for veterinary teams. The deal highlights Instinct's commitment to enhancing veterinary practice management.
Investors: xx
Health Jan 16, 2026
$1.62M
Dublin-based Luna Systems has raised โ‚ฌ1.5 million to launch its AI safety camera for cyclists. The funding round was led by Fundracer Capital and EIT Urban Mobility, with support from Enterprise Ireland. The company aims to enhance cycling safety with features like collision warnings and blind-spot detection, inspired by advanced driver assistance systems. Luna plans to market a rear-facing AI camera paired with a smartphone app to help cyclists navigate traffic more safely and confidently.
Investors: Fundracer Capital, EIT Urban Mobility, Enterprise Ireland
Health Jan 15, 2026
$29.5M
Vista AI, a provider of automated MRI scanning software, has secured $29.5 million in a Series B funding round. This investment aims to scale its FDA-cleared cardiac MRI platform and expand into additional anatomical areas. The funding was backed by various health systems and venture investors.
Health Jan 14, 2026
AstraZeneca Acquires Modella AI To Scale Multimodal AI And Agents Across Oncology R&D
Health Jan 14, 2026
$29.5M
Vista AI, a Palo Alto, CA-based company specializing in automated MRI scanning software, raised $29.5 million in Series B funding. The round was led by Cedars-Sinai Health System, Intermountain Health, University of Utah Hospital System, Temple University/Fox Chase Cancer Center, and Tampa General Hospital, with participation from Khosla Ventures and Bold Brain. This funding aims to enhance MRI scanning capabilities in hospitals and imaging centers.
Investors: Cedars-Sinai Health System, Intermountain Health, University of Utah Hospital System, Temple University/Fox Chase Cancer Center, Tampa General Hospital, Khosla Ventures, Bold Brain
Health Jan 14, 2026
$80M
New York-based biotech startup Proxima has secured $80 million in seed funding to revolutionize how medicines interact with cells. The funding round was led by DCVC, with participation from notable investors including NVIDIAโ€™s venture capital arm, nVentures. Proxima aims to address the limitations of traditional drug discovery by developing proximity-based medicines that reshape protein networks, potentially treating diseases that have resisted conventional approaches.
Investors: DCVC, nVentures
Health Jan 14, 2026